University of Michigan
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT04588714
Researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have scleroderma. Resilience-based, Energy Management to Enhance Wellbeing (RENEW) was created by researchers, doctors, and patients with scleroderma. The goal is to help people with scleroderma feel better.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The program includes unlimited website access and 10 scheduled phone calls with an assigned peer mentor.
Time frame: 12 weeks
Number of participants who complete the study
Time frame: 12 weeks
Number of completed peer-mentor calls
Time frame: 12 weeks
Number of minutes spent accessing the RENEW website/app
Time frame: 12 weeks
Time frame: 12 weeks
Preparation time of peer mentors will be documented in minutes.
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03222492
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis
Los Angeles, California, United States
View Trial DetailsNCT05204355
Connective Tissue Diseases, Scleroderma
Kansas City, Kansas, United States
View Trial DetailsNCT05995626
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Omaha, Nebraska, United States
View Trial DetailsNCT03207997
Connective Tissue Diseases, Fibrosis
Paris, France
View Trial Details